New Study Demonstrates AI-Powered Care Coordination Reduces Transfer Time and Improves Outcomes in Intracerebral Hemorrhage Patients
The case study features a 47-year-old patient with a right parieto-occipital hematoma who was rapidly identified by Viz.ai and transferred through the Neuroemergencies Management and Transfer (NEMAT) program. The use of Viz ICH and Viz ICH Plus cut the interhospital transfer time nearly in half - from an average of 200 minutes to just 101 minutes in this case - allowing the patient to undergo successful surgical evacuation and experience significant neurological recovery over the following year.
'Viz ICH has transformed how we identify and triage patients with ICH,' said Christopher Kellner, MD, Director of the Intracerebral Hemorrhage Program at Mount Sinai. 'By accelerating diagnosis and enabling real-time alerts across teams and hospitals, this technology streamlines the entire transfer process, ensuring patients get the care they need without unnecessary delays.'
Intracerebral hemorrhage accounts for up to 15% of all strokes and has high morbidity and mortality rates, requiring rapid diagnosis and intervention. Accurate volume measurements of brain bleeds are crucial for assessing the severity of cases, monitoring progression, and guiding treatment decisions. However, these measurements have traditionally been manual and time consuming. Radiologists, neurologists and neurosurgeons can incorporate Viz ICH and Viz ICH Plus seamlessly into their workflows to automate this process and support faster, more efficient care decisions.
In addition to reducing transfer time, AI-powered detection and quantification has demonstrated improved efficiency in clinical workflows, with faster hematoma volume estimation and more accurate assessments compared to manual methods. The study also highlights the scalability of the solution across large, complex hospital systems where specialized ICH care may only be available at select sites.
'At Viz.ai, we are committed to using AI to close the gaps in stroke care and bring faster, more accurate treatment to every patient—no matter where they first present,' said Molly Madziva Taitt, Ph.D., VP of Global Clinical Affairs at Viz.ai. 'This study is a powerful example of how AI can reduce delays, support earlier interventions, and ultimately improve outcomes for patients with intracerebral hemorrhage.'
To learn more about Viz ICH Plus, visit viz.ai/hyperdensity-measurements.
About Viz.ai, Inc.
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,700+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One® is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit Viz.ai.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
SourceNow Launches AI-Powered VMS to Revolutionize Healthcare Staffing — Unlocks Float Pool Efficiency and Smart Talent Matching
BOCA RATON, Fla.--(BUSINESS WIRE)-- SourceNow, a leading provider of AI-driven vendor management software (VMS), is proud to announce its official entrance into the healthcare VMS/Talent Management market. Building on its strong momentum and an unprecedented number of new contracts since its quiet private release, SourceNow VMS for Healthcare is now empowering hospitals and healthcare systems to optimize workforce management like never before. Float Pool Management + Real-Time AI Matching = Staffing Reinvented Share At the heart of the new offering is SourceNow's innovative Float Pool & Shift Management technology, designed to help healthcare organizations fully leverage their internal talent alongside trusted external per diem resources. The platform's advanced AI matching engine connects qualified clinicians, nurses, and allied health professionals to open shifts in real-time, dramatically reducing time-to-fill, improving shift attendance, and ensuring continuity of patient care. 'Healthcare leaders today are under immense pressure to do more with less, all while keeping quality and compliance at the highest standard,' said Jean-Paul Renard, CEO of SourceNow. 'Our mission is to give them AI-powered tools that match the right talent to the right job at the right time, whether that means using internal float pools or trusted agency partners. We believe this is the future of healthcare workforce management, and we're honored to help shape it.' SourceNow VMS for Healthcare: Key Features & Benefits Faster Staff Placement – Instantly match qualified staff to open shifts and reduce time-to-fill with automated job distribution and alerts. Credential & Compliance Tracking – Monitor licenses, certifications, and background checks in real-time, with automated alerts for expirations. Float Pool & Shift Management – Optimize your internal float pools and external per diem staff to fill gaps efficiently, manage live schedules, and avoid double bookings. Vendor Management – Centralize all staffing partners, standardize rates and contracts, and track vendor performance with full transparency. Automated Timesheets & Invoicing – Streamline approvals, integrate with payroll, and ensure accurate, timely payments. Real-Time Dashboards & Analytics – Make smarter staffing decisions with live metrics for fill rates, costs, and vendor performance. Mobile Access for All Users – Empower nurses, admins, and vendors to manage everything on the go. Shift Reminders & Notifications – Reduce no-shows and boost shift attendance with automated alerts. Scalable & Secure – Built to support multi-location healthcare systems with HIPAA-compliant architecture and enterprise-grade security. 24/7 Support & Custom Configurations – Get expert onboarding, personalized workflows, and dedicated support tailored to healthcare needs. About SourceNow SourceNow is an AI-first workforce management platform trusted by organizations around the globe to manage external labor, suppliers, and compliance with ease. With its expansion into the healthcare vertical, SourceNow continues to lead the industry in modern, flexible, and secure staffing solutions that empower organizations to operate smarter, faster, and with total confidence.
Business Wire
an hour ago
- Business Wire
Levelpath Recognized in the 2025 Gartner® Hype Cycle™ for Procurement and Sourcing Solutions
SAN FRANCISCO--(BUSINESS WIRE)-- Levelpath, the leader in AI-native procurement platforms, today announced its inclusion in the 2025 Gartner® Hype Cycle™ for Procurement and Sourcing Solutions. The company was recognized as a Sample Vendor for both Generative AI for Procurement and Intake Management, we believe validating Levelpath's pioneering role in transforming procurement through breakthrough AI innovation. The future of procurement is here, and it is intelligent. While procurement teams have struggled with fragmented data, manual processes, and complex workflows, Levelpath has reimagined what is possible. Built from the ground up for the AI era, their platform goes beyond simple automation by thinking, learning, and evolving with your enterprise. Procurement That Thinks for Itself Levelpath's proprietary Hyperbridge reasoning engine does not just process requests; it understands intent, predicts needs, and orchestrates complex workflows across your entire enterprise. Levelpath's results speak for themselves: Tenfold efficiency gains in sourcing and intake management Up to 70% operational efficiency gains $26 billion in enterprise spend managed through Levelpath Sixty percent reduction in cycle times through intelligent automation Complete visibility across all procurement activities in real-time The New Standard for Procurement Excellence In our opinion, the Gartner Sample Vendor inclusion validates what Levelpath customers already know: AI-native architecture delivers transformational results that retrofitted solutions simply cannot match. Here is how we feel Levelpath redefines procurement excellence: Conversational intelligence: Transform how your teams work. Natural language requests become intelligent actions. No training required. No complex interfaces. Just speak to your procurement platform as you would a trusted colleague. Autonomous operations: Levelpath's AI agents proactively manage supplier onboarding, conduct risk assessments, and ensure compliance before you even know there is an issue. Unified intelligence: One platform. One source of truth. Every supplier, every contract, every decision connected through intelligent automation that eliminates silos and accelerates outcomes. Beyond these core capabilities, Levelpath's AI-native architecture delivers specialized solutions that address procurement's most persistent challenges. Intake Management Revolutionized Levelpath transforms the procurement request experience from frustrating to effortless. Users describe what they need in plain English. The platform's AI interprets, validates, and routes requests through the right approvals automatically, ensuring compliance without compromising speed. "We believe this recognition reaffirms Levelpath's commitment to helping procurement teams navigate complexity with cutting-edge solutions that integrate technology, suppliers and business users," said Alex Yakubovich, CEO of Levelpath. "Our focus on AI-native innovation ensures procurement and the business remain competitive and future-ready in the evolving landscape." Trusted by Industry Leaders Fortune enterprises worldwide, including Ace Hardware, Amgen, Coupang, Fortrea, GATX, SiriusXM, SSM Health, and Western Union, have chosen Levelpath to transform their procurement operations. They have experienced rapid deployment, significant ROI and measurable improvements in productivity and efficiency. The competitive advantage of early AI adoption in procurement has never been clearer. Empowering Procurement Leaders Through AI Education Building on this recognition, Levelpath is launching an AI Masterclass series to accelerate AI adoption across the procurement community. The interactive sessions bring together procurement leaders from Fortune enterprises to share proven use cases, exchange best practices and transform AI curiosity into measurable results. From triaging intake requests in seconds to accelerating contract workflows, each monthly session offers attendees actionable playbooks they can implement immediately, creating a collaborative environment where procurement professionals can experiment, innovate and grow together. The Masterclass series addresses the reality that successful AI implementation in procurement requires more than technology, it demands strategic thinking, operational excellence and community learning. Through live Q&As and peer networking, participants gain insights into how AI is reshaping procurement's ability to deliver value, drive compliance and respond to business needs at unprecedented speed. Whether just beginning their AI journey or seeking to deepen expertise, procurement leaders are using these sessions to evolve from AI-curious operators into AI-powered champions, positioning their organizations for competitive advantage in the intelligent procurement era. Join Levelpath's monthly AI Masterclass series starting Friday, July 25th, featuring SSM Health and other Fortune enterprise leaders as they share proven AI procurement strategies and actionable playbooks you can implement immediately, learn more about this ongoing monthly series and register now to transform your procurement operations. To explore the full landscape of AI innovation in procurement and understand where these transformative technologies are heading, download a complimentary copy of the 2025 Gartner® Hype Cycle™ for Procurement and Sourcing Solutions to learn more about Levelpath's recognition. Gartner, Hype Cycle for Procurement and Sourcing Solutions, 2025, Kaitlynn Sommers, Micky Keck, Lynne Phelan, Cian Curtin, Chaithanya Paradarami, Martin Shreffler, 30 June 2025 *GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About Levelpath Levelpath is the leading AI-native procurement platform transforming how global enterprises manage indirect spend. Built from the ground up for the AI era, our platform unifies procurement operations through intelligent automation, featuring an intuitive stakeholder interface, advanced workflow orchestration, and our proprietary Hyperbridge reasoning engine that delivers real-time intelligence and complete visibility across all procurement activities. Trusted by leading Fortune enterprises worldwide, including Ace Hardware, Amgen, Coupang, Fortrea, GATX, SiriusXM, SSM Health, and Western Union, Levelpath's AI-native architecture enables organizations to collaborate smarter, operate faster, and scale procurement operations that drive measurable business value. Headquartered in San Francisco, Levelpath is backed by Battery, Benchmark, Redpoint Ventures, 01A, Menlo Ventures, NewView Capital, and World Innovation Lab. Learn more at or connect with us on LinkedIn.
Business Wire
2 hours ago
- Business Wire
Aptar's Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. This technology is designed to provide a singular solution to address these degradation drivers for pharmaceutical drugs, including oral solid dose glucagon-like peptide-1 (GLP-1), medical devices and more. This new solution marks a significant material science breakthrough in the pharmaceutical industry, extending Aptar CSP Technologies' 3-Phase Activ-Polymer™ technology into new use cases where a combination of humidity and oxidation can compromise the efficacy, safety, and shelf life of sensitive oral solid dose drugs, medical devices, implantable mesh devices, microarray patches and transdermal delivery systems. 'This launch reflects years of development, engineering excellence, and a deep understanding of our customers' most pressing stability challenges,' said Badre Hammond, Vice President Commercial Operations and General Manager, Aptar CSP Technologies. 'There has never been a singular, standalone active material aimed at protecting against both oxidation and moisture-related degradation at this level of precision across multiple platforms. We're proud to offer a solution that is not only scientifically differentiated but can also be commercially validated.' Aptar's new dual-active technology can be customized for a range of product formats and development stages, from early R&D to commercial launch. Aptar's technology can help support regulatory compliance and product protection across a variety of formats, aimed at helping companies meet strict International Council for Harmonization (ICH) stability requirements while maintaining performance and integrity of sensitive drug or device components. In addition to protection technology for oral solid dose GLP-1, Aptar also offers a range of high-quality elastomeric components for GLP-1 drug products, including plungers and rigid needle shields. Pharmaceutical companies have validated Aptar's elastomeric components and are partnering with Aptar to develop injectable solutions for GLP-1. By combining digital and Aptar's patient services, Aptar offers fully integrated solutions, which helps drug manufacturers create differentiated drug delivery systems and enhance patient experiences for GLP-1 and other applications. About Aptar Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Aptar CSP Technologies leverages its active material science expertise to transform ideas into market opportunities, accelerate and de-risk the product development process, and provide complete solutions that improve consumers' and patients' lives. The company offers a complete set of services from concept ideation, to design and engineering, to product development, global production, quality control, and regulatory support that results in expedited speed-to-market. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit and This press release contains forward-looking statements, including the potential outcomes of the 3-Phase Activ-Polymer™ technology. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by use of words such as 'expects,' 'anticipates,' 'believes,' 'estimates,' 'future,' 'potential,' 'continues' and other similar expressions or future or conditional verbs such as 'will,' 'should,' 'would' and 'could' are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: the successful integration of acquisitions; the regulatory environment; and competition, including technological advances. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in our Form 10-K and Forms 10-Q. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.
